Sitagliptin triazecine analog
CAS: 2088771-61-1
Ref. 3D-FS180825
| 1g | Discontinued | ||
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued | ||
| 250µg | Discontinued | ||
| 500µg | Discontinued |
Product Information
Name:
Sitagliptin triazecine analog
Description:
Sitagliptin is a pharmaceutical drug that belongs to the group of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is used to lower blood glucose levels in people with type 2 diabetes by increasing insulin release from the pancreas and by reducing the rate of breakdown of glucose-lowering medication. Sitagliptin can be administered orally, as an extended-release tablet or as an injection. It binds to human monocytes and reduces their production of proinflammatory cytokines such as TNF-α and IL-6, which are involved in the pathogenesis of atherosclerosis, diabetes, and obesity. Sitagliptin also has antihyperglycemic effects in animals.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
421.3 g/mol
Formula:
C16H13F6N5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
